Search by Drug Name or NDC
NDC 00338-0409-02 Lidocaine Hydrochloride and Dextrose 4 mg/mL Details
Lidocaine Hydrochloride and Dextrose 4 mg/mL
Lidocaine Hydrochloride and Dextrose is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is LIDOCAINE HYDROCHLORIDE.
Product Information
| NDC | 00338-0409 |
|---|---|
| Product ID | 0338-0409_ea052102-b3a3-422a-851c-512646352c78 |
| Associated GPIs | 35200020112020 |
| GCN Sequence Number | 060684 |
| GCN Sequence Number Description | lidocaine HCl/dextrose 5 %/PF IV SOLN 4 MG/ML INTRAVEN |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 26898 |
| HICL Sequence Number | 033594 |
| HICL Sequence Number Description | LIDOCAINE HCL IN DEXTROSE 5% IN WATER/PF |
| Brand/Generic | Generic |
| Proprietary Name | Lidocaine Hydrochloride and Dextrose |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lidocaine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/mL |
| Substance Name | LIDOCAINE HYDROCHLORIDE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA018461 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00338-0409-02 (00338040902)
| NDC Package Code | 0338-0409-02 |
|---|---|
| Billing NDC | 00338040902 |
| Package | 24 BAG in 1 CARTON (0338-0409-02) / 250 mL in 1 BAG |
| Marketing Start Date | 1981-04-22 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |